Group A Streptococcus (GAS)

The development of a safe and effective GAS vaccine to reduce the GAS disease burden is now clearly recognized as a priority by the WHO, vaccine developers and other key stakeholders - Stephan Brouwer

Group A Streptococcus (GAS)

image by: All Things Microbial

HWN Suggests

Pathogenesis, epidemiology and control of Group A Streptococcus infection

GAS outbreaks continue to emerge across the globe, causing significant disease incidence, requiring vigilant monitoring with ongoing efforts integrating both research and public health laboratories key to defining evolutionary trajectories of pathogenic GAS populations. Although the epidemiology of GAS infection has shifted substantially in some developed countries over the last century in line with changing social-economic factors, coordinated efforts to build capacity and surveillance nodes in low-resource settings are essential to both defining GAS transmission chains and providing a framework to assess the impact of future preventative measures.

read full article

Resources

 Pathogenesis, epidemiology and control of Group A Streptococcus infection

GAS outbreaks continue to emerge across the globe, causing significant disease incidence, requiring vigilant monitoring with ongoing efforts integrating both research and public health laboratories key to defining evolutionary trajectories of pathogenic GAS populations. Although the epidemiology of GAS infection has shifted substantially in some developed countries over the last century in line with changing social-economic factors, coordinated efforts to build capacity and surveillance nodes in low-resource settings are essential to both defining GAS transmission chains and providing a framework to assess the impact of future preventative measures.

National Collaborating Centre for Infectious Diseases

The group A streptococcal infections can range from mild and uncomplicated such as acute GAS pharyngitis to life threating invasive GAS infections such as STSS.

CDC

Bacteria called group A Streptococcus (group A strep) can cause many different infections.

MedicineNet

Symptoms and signs of GAS disease are variable and are related to the body area that is undergoing the infection; for example, sore throat, throat erythema, and swollen lymph nodes in strep throat to low blood pressure and organ failure in toxic shock syndrome.

National Centre for Infectious Diseases

GAS causes a variety of superficial and invasive infections, with occasional immunological sequelae. Globally, the incidence of major syndromes caused by GAS has seen striking changes over the decades. Rates of acute rheumatic fever have fallen worldwide over the past century, while a surge in severe invasive cases was noticed in many countries including Singapore in the 1980’s to 1990’s. In the past decade, scarlet fever outbreaks – infrequently reported since the 19th century – have occurred in multiple countries including UK, China, USA, Hong Kong, and Canada.

Sepsis Alliance

While it’s common for group A strep to exist in your throat and nose, and on your skin, it is not common inside your body. When these bacteria enter your body, they can cause infections such as necrotizing fasciitis (often called “flesh eating disease”) and toxic shock syndrome.

StatPearls

Infections due to GAS result in acute pharyngitis, impetigo, erysipelas, and cellulitis. GAS also tends to produce manifestations of more invasive diseases, including streptococcal toxic shock syndrome and necrotizing fasciitis.

Introducing Stitches!

Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!

Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.


Be the first to know when Stitches starts accepting users


Health Cloud

Stay Connected